NM_018136.5:c.7939C>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_018136.5(ASPM):​c.7939C>A​(p.Leu2647Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.389 in 1,610,322 control chromosomes in the GnomAD database, including 129,579 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. L2647L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.30 ( 8818 hom., cov: 32)
Exomes 𝑓: 0.40 ( 120761 hom. )

Consequence

ASPM
NM_018136.5 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11O:1

Conservation

PhyloP100: 0.00200

Publications

36 publications found
Variant links:
Genes affected
ASPM (HGNC:19048): (assembly factor for spindle microtubules) This gene is the human ortholog of the Drosophila melanogaster 'abnormal spindle' gene (asp), which is essential for normal mitotic spindle function in embryonic neuroblasts. Studies in mouse also suggest a role of this gene in mitotic spindle regulation, with a preferential role in regulating neurogenesis. Mutations in this gene are associated with microcephaly primary type 5. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2011]
ASPM Gene-Disease associations (from GenCC):
  • microcephaly 5, primary, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0046061575).
BP6
Variant 1-197101312-G-T is Benign according to our data. Variant chr1-197101312-G-T is described in ClinVar as Benign. ClinVar VariationId is 21611.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.432 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_018136.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ASPM
NM_018136.5
MANE Select
c.7939C>Ap.Leu2647Ile
missense
Exon 18 of 28NP_060606.3
ASPM
NM_001206846.2
c.4066-5148C>A
intron
N/ANP_001193775.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ASPM
ENST00000367409.9
TSL:1 MANE Select
c.7939C>Ap.Leu2647Ile
missense
Exon 18 of 28ENSP00000356379.4
ASPM
ENST00000294732.11
TSL:1
c.4066-5148C>A
intron
N/AENSP00000294732.7
ASPM
ENST00000367408.6
TSL:1
n.2108-5148C>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.305
AC:
46211
AN:
151428
Hom.:
8822
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0946
Gnomad AMI
AF:
0.406
Gnomad AMR
AF:
0.268
Gnomad ASJ
AF:
0.399
Gnomad EAS
AF:
0.157
Gnomad SAS
AF:
0.290
Gnomad FIN
AF:
0.373
Gnomad MID
AF:
0.446
Gnomad NFE
AF:
0.436
Gnomad OTH
AF:
0.329
GnomAD2 exomes
AF:
0.334
AC:
83078
AN:
248402
AF XY:
0.345
show subpopulations
Gnomad AFR exome
AF:
0.0888
Gnomad AMR exome
AF:
0.209
Gnomad ASJ exome
AF:
0.390
Gnomad EAS exome
AF:
0.164
Gnomad FIN exome
AF:
0.365
Gnomad NFE exome
AF:
0.431
Gnomad OTH exome
AF:
0.369
GnomAD4 exome
AF:
0.397
AC:
579850
AN:
1458776
Hom.:
120761
Cov.:
47
AF XY:
0.397
AC XY:
287812
AN XY:
725780
show subpopulations
African (AFR)
AF:
0.0826
AC:
2759
AN:
33398
American (AMR)
AF:
0.217
AC:
9644
AN:
44498
Ashkenazi Jewish (ASJ)
AF:
0.393
AC:
10238
AN:
26056
East Asian (EAS)
AF:
0.154
AC:
6084
AN:
39592
South Asian (SAS)
AF:
0.308
AC:
26531
AN:
86192
European-Finnish (FIN)
AF:
0.370
AC:
19598
AN:
52958
Middle Eastern (MID)
AF:
0.370
AC:
2092
AN:
5652
European-Non Finnish (NFE)
AF:
0.433
AC:
480519
AN:
1110216
Other (OTH)
AF:
0.372
AC:
22385
AN:
60214
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
20733
41466
62200
82933
103666
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14150
28300
42450
56600
70750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.305
AC:
46211
AN:
151546
Hom.:
8818
Cov.:
32
AF XY:
0.301
AC XY:
22266
AN XY:
74044
show subpopulations
African (AFR)
AF:
0.0944
AC:
3912
AN:
41438
American (AMR)
AF:
0.268
AC:
4060
AN:
15176
Ashkenazi Jewish (ASJ)
AF:
0.399
AC:
1382
AN:
3464
East Asian (EAS)
AF:
0.158
AC:
807
AN:
5120
South Asian (SAS)
AF:
0.292
AC:
1407
AN:
4816
European-Finnish (FIN)
AF:
0.373
AC:
3933
AN:
10544
Middle Eastern (MID)
AF:
0.449
AC:
132
AN:
294
European-Non Finnish (NFE)
AF:
0.436
AC:
29522
AN:
67690
Other (OTH)
AF:
0.328
AC:
688
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1503
3006
4510
6013
7516
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
464
928
1392
1856
2320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.386
Hom.:
41099
Bravo
AF:
0.286
TwinsUK
AF:
0.434
AC:
1609
ALSPAC
AF:
0.430
AC:
1656
ESP6500AA
AF:
0.104
AC:
460
ESP6500EA
AF:
0.435
AC:
3737
ExAC
AF:
0.339
AC:
41138
Asia WGS
AF:
0.202
AC:
706
AN:
3476
EpiCase
AF:
0.422
EpiControl
AF:
0.425

ClinVar

Significance: Benign
Submissions summary: Benign:11Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:4
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 02, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Microcephaly 5, primary, autosomal recessive Benign:3Other:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
5.8
DANN
Benign
0.92
DEOGEN2
Benign
0.032
T
Eigen
Benign
-0.29
Eigen_PC
Benign
-0.53
FATHMM_MKL
Benign
0.23
N
LIST_S2
Benign
0.80
T
MetaRNN
Benign
0.0046
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.2
M
PhyloP100
0.0020
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-0.75
N
REVEL
Benign
0.20
Sift
Benign
0.20
T
Sift4G
Benign
0.21
T
Polyphen
0.99
D
Vest4
0.18
ClinPred
0.0097
T
GERP RS
-1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.084
gMVP
0.0030
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3762271; hg19: chr1-197070442; COSMIC: COSV54126748; API